Pacific Standard: A New Website Shows Nearly Half Of E.U. Clinical Trial Data Isn’t Publicly Disclosed

Pacific Standard: A New Website Shows Nearly Half Of E.U. Clinical Trial Data Isn’t Publicly Disclosed. “Three researchers created a website earlier this year to name and shame pharmaceutical companies and universities in the United States that break a law that activists say is critical to patient safety. Now, the three have joined a few others to do the same for the European Union, creating a website that names 3,755 clinical trials—studies, done with human volunteers, of the safety and efficacy of new prescription drugs, vaccines, and medical devices—that have passed their deadlines for posting results publicly to the E.U. Clinical Trials Register.”

NoCamels: Scientists Harness AI, Deep Learning To Fast-Track Drug Discovery And Development

NoCamels: Scientists Harness AI, Deep Learning To Fast-Track Drug Discovery And Development. “The cost of developing a new pharmaceutical drug, from the research and development stage to market approval, runs at about $2.6 billion, according to a 2014 report published by the Tufts Center for the Study of Drug Development (CSDD) cited by the Scientific American. It also takes between 10 to 15 years. Israeli scientists say they have developed a revolutionary smart method to discover and develop new drugs, based on artificial intelligence and machine learning, that will dramatically shorten preparation time and reduce costs.”

New York Times: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

New York Times: Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals. “One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and The Lancet.”

NIH: NIH makes STRIDES to accelerate discoveries in the cloud

NIH: NIH makes STRIDES to accelerate discoveries in the cloud. “The National Institutes of Health has launched a new initiative to harness the power of commercial cloud computing and provide NIH biomedical researchers access to the most advanced, cost-effective computational infrastructure, tools and services available. The STRIDES (Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability) Initiative launches with Google Cloud as its first industry partner and aims to reduce economic and technological barriers to accessing and computing on large biomedical data sets to accelerate biomedical advances.”

University of Southern California: Virtual reality tool designed at USC corrects errors in brain scan data

University of Southern California: Virtual reality tool designed at USC corrects errors in brain scan data. “In recent years, virtual reality technology has begun proving its worth outside the world of gaming, with applications in education, health care, military training and beyond. Now researchers at the Mark and Mary Stevens Neuroimaging and Informatics Institute at the Keck School of Medicine of USC are exploring a new frontier: VR as a tool for processing brain scan data.”

Bloomberg Quint: Google’s DeepMind To Create Product to Spot Eye Disease

Bloomberg Quint: Google’s DeepMind To Create Product to Spot Eye Disease. “DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc., plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.”

KUT: A New Database Could Help Prevent Asthma Attacks Among Austin Children

KUT: A New Database Could Help Prevent Asthma Attacks Among Austin Children. “Researchers and data experts at the Dell Medical School at the University of Texas at Austin say a new database will help doctors treat children with asthma, while helping parents better understand how to reduce the frequency of attacks. With funding from the Michael & Susan Dell Foundation, a team at the Dell Medical School at UT Austin is trying to help patients and doctors track and mitigate environmental conditions that trigger asthma attacks.”